VisionLifesciences

Pharma & Biotech Business Development Advisors

Your partner in cross-border licensing, partnerships, and deal-making for global pharma and life sciences.

In-Licensing

Acquire rights to innovative therapeutics and technologies.

Out-Licensing

Monetize your IP and product portfolios globally.

Strategic Partnerships

Build cross-border alliances in pharma and biotech.

Global Network

Deep connections across Asia, Europe, and USA.

Vision Lifesciences

Your Partner in Cross-Border Life Sciences Deals

We facilitate global partnerships and financing in life sciences, connecting Asia, Europe, and USA to accelerate innovation to market.

Global
Tri-Continental Network
Proven
Cross-Border Deal Expertise
Billions
In Transaction Opportunity

Solutions for Life Sciences Cross-Border Collaborations

In-Licensing. Acquire rights to innovative therapeutics and technologies from global partners.

In-licensing deals and partnerships

Out-Licensing. Monetize your IP and product portfolios through strategic licensing agreements.

Out-licensing opportunities

Strategic Partnerships. Build cross-border alliances for drug development, manufacturing, and commercialization.

Connected
Global Partner Ecosystem

NewCo Formation. Spin off assets into new independent entities to access global capital and expertise.

Launched
Multiple NewCos to Market

Capital Access. Connect clients with investors and structure financial deals from seed to late-stage.

Funded
Capital Raised

Core Capabilities for Pharmaceutical and Biotech Success

Our specialized knowledge and vast connections make us the ideal catalyst for cross-border collaborations in the life sciences industry.

Maximize value in licensing transactions.

We facilitate in-licensing agreements, balancing upfront payments, milestones, and royalties for optimal outcomes. Our expertise ensures you secure the right assets at the right terms.
In-Licensing

Latest Insights

Looking for hidden opportunities in global pharma? Our insights reveal them.

Biotech M&A 2026: Navigating the $200B Patent Cliff

Biotech M&A 2026: Navigating the $200B Patent Cliff

A technical analysis of valuation multiples and integration savings in the consolidation wave.

Pharma Business Development: The 2026 Definitive Guide

Pharma Business Development: The 2026 Definitive Guide

Transforming the BD function from a transactional support role into a core scientific strategy engine.

China Biotech Licensing 2026: The Definitive Technical Guide

China Biotech Licensing 2026: The Definitive Technical Guide

Navigating the world's second-largest market: From NMPA acceleration to the ADC licensing surge.

Frequently Asked Questions

Looking for a Collaboration?

Let's discuss how we can help you accelerate your cross-border deals in pharma and life sciences.